EDESA BIOTECH, INC.: 10-Q filed 2024-02-09

Name: EDESA BIOTECH, INC.: 10-Q filed 2024-02-09
Creator: EDESA BIOTECH, INC.

What EDESA BIOTECH, INC. reported in its quarterly report filed 2024-02-09 (fiscal Q1 2024): 28 published measures, 59 facts as tagged in accession 0001654954-24-001540.

This filing

Form: 10-Q (quarterly report)
Filed: 2024-02-09
Fiscal period: fiscal Q1 2024
Accession: 0001654954-24-001540 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All EDESA BIOTECH, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2023-12-31	7,831,790	USD
At 2023-09-30	8,890,437	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2023-12-31	1,986,912	USD
At 2023-09-30	1,841,637	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit
At 2023-12-31	5,844,878	USD
At 2023-09-30	7,048,800	USD
At 2022-12-31	10,273,456	USD
At 2022-09-30	9,391,289	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2023-10-01 to 2023-12-31	-1,678,451	USD	92
2022-10-01 to 2022-12-31	-2,334,817	USD	92

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2023-10-01 to 2023-12-31	-1,406,528	USD	92
2022-10-01 to 2022-12-31	-1,791,095	USD	92

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2023-10-01 to 2023-12-31	305,742	USD	92
2022-10-01 to 2022-12-31	2,911,775	USD	92

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2023-10-01 to 2023-12-31	0	USD	92
2022-10-01 to 2022-12-31	0	USD	92

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2023-12-31	-54,097,419	USD
At 2023-09-30	-52,418,968	USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2023-12-31	8,188	USD
At 2023-09-30	8,702	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2023-10-01 to 2023-12-31	184,357	USD	92
2022-10-01 to 2022-12-31	333,675	USD	92

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2023-10-01 to 2023-12-31	-1,857,429	USD	92
2022-10-01 to 2022-12-31	-2,378,305	USD	92

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2023-12-31	5,416,259	USD
At 2023-09-30	6,436,852	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2023-12-31	1,986,912	USD
At 2023-09-30	1,821,864	USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

Period	Value	Unit	Days
At 2023-12-31	2,154,727	USD
At 2023-09-30	2,180,020	USD

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2023-10-01 to 2023-12-31	704,458	USD	92
2022-10-01 to 2022-12-31	1,357,338	USD	92

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2023-12-31	3,164,722	shares
At 2023-09-30	3,075,473	shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

Period	Value	Unit
At 2023-12-31	4,267,787	USD
At 2023-09-30	5,361,397	USD
At 2022-12-31	8,270,207	USD
At 2022-09-30	7,090,919	USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2023-12-31	13,223,622	USD
At 2023-09-30	13,039,265	USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2023-12-31	-215,220	USD
At 2023-09-30	-214,648	USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

Period	Value	Unit	Days
At 2023-12-31	74,885	USD
At 2023-09-30	91,373	USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

Period	Value	Unit	Days
At 2023-12-31	78,314	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2023-12-31	404,903	USD
At 2023-09-30	448,912	USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

Period	Value	Unit	Days
2023-10-01 to 2023-12-31	-1,678,451	USD	92
2022-10-01 to 2022-12-31	-2,334,817	USD	92

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

Period	Value	Unit	Days
2023-10-01 to 2023-12-31	-1,679,023	USD	92
2022-10-01 to 2022-12-31	-2,359,884	USD	92

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2023-10-01 to 2023-12-31	1,152,971	USD	92
2022-10-01 to 2022-12-31	1,020,967	USD	92

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

Period	Value	Unit	Days
2023-10-01 to 2023-12-31	30,000	USD	92
2022-10-01 to 2022-12-31	30,000	USD	92

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2023-10-01 to 2023-12-31	178,978	USD	92
2022-10-01 to 2022-12-31	43,488	USD	92

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2023-10-01 to 2023-12-31	315,201	USD	92
2022-10-01 to 2022-12-31	3,027,496	USD	92

Inspect the source

Entity: EDESA BIOTECH, INC. / CIK 0001540159
Captured: 2026-09-20T09:17:32.413Z
SEC response SHA-256: 0f44de1ccf1eff46a1af17dc21d4a3bb38216bbf46e813f5a136d29e08bfd65d

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001540159.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))